ChampioNIR
Peripheral artery disease
InvestigationalActive
Key Facts
About Medinol
Innovative cardiovascular device maker with CE‑approved drug‑eluting stents and emerging implantable sensor platform.
View full company profileTherapeutic Areas
Other Peripheral artery disease Drugs
| Drug | Company | Phase |
|---|---|---|
| Peripheral Artery Disease Program | Elixir Medical | Pre-clinical |
| Aperta NSE™ PTA | Nipro Medical | Commercial |
| JTV-263 | Akros Pharma | Phase1 |
| Luminor DCB | iVascularU | Post-Market |
| iVolution pro Stent | iVascularU | Post-Market |
| FGF-1 | Zhittya Genesis Medicine | Phase 2 |
| Ranger DCB | Boston Scientific | Pivotal Trial |